About Us
Committed to building a high-end China focused medical device enterprise that meets international standards, integrating R&D and production into one cohesive company.

Scroll down

NewMed
Focus on the R&D and industrialization of heart valve devices with the latest international technology

Founded in 2015, Shanghai NewMed Medical Co., Ltd. ("NewMed") is an innovative, high-end medical device enterprise with independent intellectual property rights, focusing on the R&D and industrialization of heart valve devices with the latest international technology.


NewMed cares about patients with heart valve disease, understands the clinical needs of doctors, adheres to the concept of professionalism, safety, and efficiency, and collaborates with experts in the field of cardiovascular diseases to provide more high-end medical devices that can benefit patients. NewMed is committed to building a high-end medical device enterprise rooted in China, synchronized with international standards while integrating R&D and production, to fulfill the mission – "innovations improve life".


Based on innovative research and development, academic promotion and treatment popularization, NewMed has set up a management team that gathers industrial talents, academic experts, researchers, and clinicians to establish cooperative relationships with well-known domestic hospitals and universities. NewMed is committed to developing more innovative medical device products, filling the gaps in domestic products and technology, and benefiting patients.

  • 3

    The company that

    has 3 products recognized

    as innovative medical

    devices qualified for Special Review

  • 16

     

    16 product candidates

     

  • 300

    Filed over 300 patent applications

History
2021
  • We completed the Series C Financing.
  • We completed the FIM clinical trial and commenced the confirmatory clinical trial for Prizvalve®, and the NMPA recognized Prizvalve® as an innovative medical device qualified for Special Review.
  • Valveclip-M was approved by the NMPA for its clinical trial, and the NMPA recognized Valveclip-M™ as an innovative medical device qualified for Special Review.
History
2020
  • We completed the Series B Financing and the Series B+ Financing.
  • Chengdu NewMed, our wholly-owned subsidiary, was established.
  • We were awarded the 3rd Prize of the 3rd China Medical Devices Design & Entrepreneurship Competition, 2020.
  • Prizvalve® was approved by the NMPA for clinical trials, and the first humanitarian treatment using Prizvalve® was completed.
  • Mi-thos® was approved by the NMPA for clinical trials, and the NMPA recognized Mi-thos® as an innovative medical device qualified for Special Review.
  • We initiated an animal study of Valveclip-M™.
History
2019
  • We obtained the certificate of high-technology enterprise in 2019.
  • We won the 2019 Shanghai Pudong New District Science and Technology Development Fund – Industry-Study-Research Special Project in Biomedical Field.
  • We initiated an animal study of Prizvalve®.
  • The first humanitarian treatment using Mi-thos® was completed.  
History
2018
  • We completed the Series A Financing and the Series A+ Financing.
  • We were awarded the Star Science and Technology Enterprise of the 30th Anniversary of Shanghai Technology Business Incubation

 

History
2017
  • We initiated an animal study of Mi-thos®
History
2016
  • We completed the Series Pre-A Financing.
  • We participated in the Ministry of Science and Technology of the PRC for the China National Key R&D Program during the 13th Five-Year Plan Period.
  • We were awarded the third place in the biomedicine group of the 5th China Innovation & Entrepreneurship Competition.
History
2015
  • Shanghai NewMed Medical Company Limited was established.
  • We completed the Angel Investment.

2021

2020

2019

2018

2017

2016

2015

Leadership
We are led by a visionary and strategically insightful management team.
Honors
2021

Shanghai patent pilot enterprise

TOP 10 of China's innovative medical device enterprise of 2021

The Best Enterprise of Innovative Medical Device of the Year of Healthcare Investment Excellent List

NewMed Biotechnology : the key R&D project in 2021 Chengdu major scientific and technological innovation project

2020

Awarded the 3rd Prize of the 3rd China Medical Devices Design & Entrepreneurship Competition, 2020

2019

Shanghai high-technology enterprise

Shanghai Pudong New District Science and Technology Development Fund – Industry-Study-Research Special Project in Biomedical Field

2018

Science and Technology Support Project in the Biomedicine Field of the Shanghai "Science and Technology Innovation Action Plan" in 2018

Star Science and Technology Enterprise of the 30th Anniversary of Shanghai Technology Business Incubation

2017

Science and Technology Support Project in the Field of Biomedicine of the Shanghai "Science and Technology Innovation Action Plan"

2016

Participated in the Ministry of Science and Technology of the PRC for the China National Key R&D Program during the 13th Five-Year Plan Period

Awarded the third place in the biomedicine group of China Innovation & Entrepreneurship Competition

Culture